Evidence map›Paper›PMID 15923611›Full record

ArticleMolecular and cellular biology2005

Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases.

Tomas Brdicka, Theresa A Kadlecek, Jeroen P Roose, Alexander W Pastuszak, Arthur Weiss

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. AFrontiers in immunology · 2026
    Article
  3. Platelet Membrane Receptors and Signalling Pathways.Handbook of experimental pharmacology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. ZAP-70 in Signaling, Biology, and Disease.Annual review of immunology · 2018
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tomas BrdickaDepartment of Medicine, The Rosalind Russell Medical Research Center for Arthritis and Howard Hughes Medical Institute, University of California at San Francisco, 533 Parnassus Avenue, San Francisco, CA 94143-0795, USA.
Theresa A Kadlecek
Jeroen P Roose
Alexander W Pastuszak
Arthur Weiss
Howard Hughes Medical Institute · USUniversity of California, San Francisco · US

Funding

PHS HHS A135297
6 · The paper itself

Abstract

ZAP-70, a Syk family cytoplasmic protein tyrosine kinase (PTK), is required to couple the activated T-cell antigen receptor (TCR) to downstream signaling pathways. It contains two tandem SH2 domains that bind to phosphorylated TCR subunits and a C-terminal catalytic domain. The region connecting the SH2 domains with the kinase domain, termed interdomain B, has previously been shown to have striking regulatory effects on ZAP-70 function, presumed to be due to the recruitment of key substrates. Paradoxically, deletion of interdomain B preserves ZAP-70 function. Recent structural studies of several receptor tyrosine kinases (RTKs) revealed that their juxtamembrane regions negatively regulate their catalytic activities. In EphB2 and several other RTKs, this autoinhibition depends upon interaction between the kinase domain and tyrosine residues within the juxtamembrane region. Autoinhibition is released when these tyrosines become phosphorylated following receptor stimulation. Sequence homology suggested analogous regulation for ZAP-70. Based on mutagenesis analysis of ZAP-70 interdomain B, we find that this region downregulates ZAP-70 catalytic activity in a similar manner as the juxtamembrane region of EphB2. Similar regulation was also noted for the related Syk kinase. These findings suggest that a general autoinhibitory mechanism employed by RTKs is also used by some cytoplasmic tyrosine kinases.

Indexed as

Amino Acid SequenceAnimalsCalciumCell LineEnzyme ActivationEnzyme PrecursorsGenes, ReporterHumansIntracellular Signaling Peptides and ProteinsMolecular Sequence DataPhosphorylationProtein-Tyrosine KinasesRatsReceptor, EphB2Receptor Protein-Tyrosine KinasesReceptors, Antigen, T-CellCalciumEnzyme PrecursorsIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesReceptor, EphB2Receptor Protein-Tyrosine KinasesReceptors, Antigen, T-CellSyk KinaseSYK protein, humanSyk protein, ratTyrosineZAP70 protein, humanZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID15923611
PMCPMC1140569
OpenAlexW2105562449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.